BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 21622235)

  • 1. Effects of opioids, cannabinoids, and vanilloids on body temperature.
    Rawls SM; Benamar K
    Front Biosci (Schol Ed); 2011 Jun; 3(3):822-45. PubMed ID: 21622235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interactions between delta- and mu-opioid receptors in rat thermoregulation.
    Salmi P; Kela J; Arvidsson U; Wahlestedt C
    Eur J Pharmacol; 2003 Jan; 458(1-2):101-6. PubMed ID: 12498912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid-opioid interactions during neuropathic pain and analgesia.
    Bushlin I; Rozenfeld R; Devi LA
    Curr Opin Pharmacol; 2010 Feb; 10(1):80-6. PubMed ID: 19857996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cannabinoid receptor in the brain as it relates to drug reward.
    Yamamoto T; Takada K
    Jpn J Pharmacol; 2000 Nov; 84(3):229-36. PubMed ID: 11138722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body temperature and analgesic effects of selective mu and kappa opioid receptor agonists microdialyzed into rat brain.
    Xin L; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1997 Apr; 281(1):499-507. PubMed ID: 9103537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic interactions between cannabinoid and opioid analgesics.
    Cichewicz DL
    Life Sci; 2004 Jan; 74(11):1317-24. PubMed ID: 14706563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid and Cannabinoid System in Food Intake.
    Pomorska DK; do-Rego JC; do-Rego JL; Zubrzycka M; Janecka A
    Curr Pharm Des; 2016; 22(10):1361-70. PubMed ID: 26806346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The opioid system and temperature regulation.
    Adler MW; Geller EB; Rosow CE; Cochin J
    Annu Rev Pharmacol Toxicol; 1988; 28():429-49. PubMed ID: 2837979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the transient receptor potential vanilloid 1 antagonist A-425619 on body temperature and thermoregulation in the rat.
    Mills C; McMackin M; Jaffe R; Yu J; Zininberg E; Slee D; Gogas K; Bradbury M
    Neuroscience; 2008 Sep; 156(1):165-74. PubMed ID: 18706981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociceptin.
    Chen X; McClatchy DB; Geller EB; Liu-Chen L; Tallarida RJ; Adler MW
    Brain Res; 2001 Jun; 904(2):252-8. PubMed ID: 11406123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia.
    Rawls SM; Cowan A; Tallarida RJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 2002 Oct; 303(1):395-402. PubMed ID: 12235276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid Ligands Targeting TRP Channels.
    Muller C; Morales P; Reggio PH
    Front Mol Neurosci; 2018; 11():487. PubMed ID: 30697147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.
    Pacheco Dda F; Klein A; Perez AC; Pacheco CM; de Francischi JN; Reis GM; Duarte ID
    Br J Pharmacol; 2009 Sep; 158(1):225-31. PubMed ID: 19594755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.
    Ledent C; Valverde O; Cossu G; Petitet F; Aubert JF; Beslot F; Böhme GA; Imperato A; Pedrazzini T; Roques BP; Vassart G; Fratta W; Parmentier M
    Science; 1999 Jan; 283(5400):401-4. PubMed ID: 9888857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modality-specific peripheral antinociceptive effects of μ-opioid agonists on heat and mechanical stimuli: Contribution of sigma-1 receptors.
    Montilla-García Á; Perazzoli G; Tejada MÁ; González-Cano R; Sánchez-Fernández C; Cobos EJ; Baeyens JM
    Neuropharmacology; 2018 Jun; 135():328-342. PubMed ID: 29580951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell.
    Korzh A; Keren O; Gafni M; Bar-Josef H; Sarne Y
    Brain Res; 2008 Jan; 1189():23-32. PubMed ID: 18068691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice.
    Berrendero F; Mendizábal V; Murtra P; Kieffer BL; Maldonado R
    Eur J Neurosci; 2003 Oct; 18(8):2197-202. PubMed ID: 14622180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia.
    Akopian AN; Ruparel NB; Jeske NA; Patwardhan A; Hargreaves KM
    Trends Pharmacol Sci; 2009 Feb; 30(2):79-84. PubMed ID: 19070372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.